Autonomix Medical, Inc.

For the period ended Mar 31, 2025. Filed May 29, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed May 29, 2025

AMIX$1.85+8.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Balance Sheets as of March 31, 2025 and 2024

Balance Sheets

(in thousands, except par value and share data)	As of
	March 31,
	2025	2024
Assets
Current assets:
Cash and cash equivalents	$9,136	$8,608
Other current assets	473	783
Total current assets	9,609	9,391
Long-term assets:
Fixed assets, net	21	16
Deferred offering costs	176	—
Total long-term assets	197	16
Total Assets	$9,806	$9,407
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$676	$492
Accrued expenses	1,031	285
Total current liabilities	1,707	777
Long-term liabilities:
Long term debt - convertible notes, net of unamortized debt discount	—	1,002
Total long-term liabilities	—	1,002
Total Liabilities	1,707	1,779
Commitments and contingencies (Note 5)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively.	—	—
Common stock, $0.001 par value, 500,000,000 shares authorized, 2,497,033 and 942,575 shares issued and outstanding as of March 31, 2025 and March 31, 2024, respectively.	2	1
Additional paid-in capital	58,476	46,596
Accumulated deficit	(50,379)	(38,969)
Total Stockholders' Equity	8,099	7,628
Total Liabilities and Stockholders' Equity	$9,806	$9,407

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.